49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Periodic Acid Solvents: Acetonitrile; 1 H,Rt1.2 Catalysts: Chromium Trioxide; 5 Min,Rt1.3 Solvents: Ethyl Acetate; 45 Min,0 °C; 1 H,0 °C1.4 Reagents: Sodium Sulfite Solvents: Water; 0 °C 标题:Chromium(Vi) Oxide Catalyzed Oxidation Of Sulfides To Sulfones With Periodic Acid 作者:Xu,Liang; Cheng,Jie; Trudell,Mark L. 参考文献:Journal Of Organic Chemistry 日期:2003 卷标:68(13) 页码:5388-5391]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Hydrogen Peroxide Catalysts: Ammonium Molybdate ((Nh4)6Mo7O24) Solvents: Ethanol,Water; 0 °C; 0 °C -> Rt; Overnight,Rt 标题:Preparation Of Aminopyrimidine Compounds Useful For The Treatment Of Egfr Mutant Kinase Mediated Diseases 参考文献:China]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: M-Chloroperbenzoic Acid Solvents: Dichloromethane; 0 °C; 0 °C -> Rt; 2.5 H,Rt 标题:Preparation Of Indazole Compounds That Inhibit One Or More Receptor,Or Non-Receptor,Tyrosine Or Serine/threonine Kinase 参考文献:World Intellectual Property Organization]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Hydrogen Peroxide Catalysts: Ammonium Molybdenum Oxide Solvents: Ethanol,Water; 2 H,Rt 标题:Improved Process For Preparing Lazertinib And Intermediates Thereof 参考文献:World Intellectual Property Organization]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Potassium Peroxymonosulfate Sulfate (2Khso5.Khso4.K2So4) Solvents: Tetrahydrofuran,Water; 15 Min,0 °C; 0 °C -> Rt; 18 H,Rt 标题:Therapeutic Compounds And Methods Of Use Thereof 参考文献:United States]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Potassium Peroxymonosulfate Sulfate (2Khso5.Khso4.K2So4) Solvents: Tetrahydrofuran,Water; 15 Min,0 °C; 0 °C -> Rt; 18 H,Rt 标题:Systematically Mitigating The P38α Activity Of Triazole-Based Bet Inhibitors 作者:Carlson,Angela S.; Cui,Huarui; Divakaran,Anand; Johnson,Jorden A.; Brunner,Ryan M.; Et Al 参考文献:Acs Medicinal Chemistry Letters 日期:2019 卷标:10(9) 页码:1296-1301]
= 97229-11-3 [标题:Reaction Conditions 标题:Preparation Heteroaryl Pyrimidinylamine Compounds And Compositions For Modulating Egfr Mutant Kinase Activities 参考文献:United States]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Hydrogen Peroxide Catalysts: Ammonium Molybdate ((Nh4)6Mo7O24) Solvents: Ethanol,Water; 0 °C; 24 H,0 °C 标题:Synthesis Of Cytimidine Through A One-Pot Copper-Mediated Amidation Cascade 作者:Serrano,Catherine M.; Looper,Ryan E. 参考文献:Organic Letters 日期:2011 卷标:13(19) 页码:5000-5003]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: M-Chloroperbenzoic Acid Solvents: Dichloromethane; 2 H,Rt 标题:Preparation Of Variolin B Derivatives As Antitumor Agents 参考文献:World Intellectual Property Organization]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Hydrogen Peroxide Catalysts: Ammonium Molybdate ((Nh4)6Mo7O24) Tetrahydrate Solvents: Ethanol; 10 °C; 12 H,37 °C1.2 Reagents: Sodium Sulfite Solvents: Water; 7 °C 标题:Sulfone Displacement Approach For Large-Scale Synthesis Of 4-Chloro-N-(1-Methyl-1H-Pyrazol-4-Yl)Pyrimidin-2-Amine 作者:Li,Chaomin; Haeffner,Fredrik; Wang,Shujun; Yuan,Cuicui; Shang,Deju; Et Al 参考文献:Organic Process Research & Development 日期:2022 卷标:26(1) 页码:137-143]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: Hydrogen Peroxide,Ammonium Molybdate ((Nh4)6Mo7O24) Tetrahydrate Solvents: Ethanol,Water; 0 °C; 0 °C -> Rt; Overnight,Rt 标题:Aminopyrimidine Compound Used For Inhibiting Activity Of Protein Kinase 参考文献:World Intellectual Property Organization]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: M-Chloroperbenzoic Acid Solvents: Dichloromethane; -5 °C; 30 Min,-5 °C; Overnight,-5 °C -> Rt 标题:Design,Synthesis,And Activity Of 2-Imidazol-1-Ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors 作者:Davey,David D.; Adler,Marc; Arnaiz,Damian; Eagen,Keith; Erickson,Shawn; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2007 卷标:50(6) 页码:1146-1157]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: M-Chloroperbenzoic Acid Solvents: Dichloromethane; 0 °C; 2 H,Rt 标题:Heterocyclic Compounds For Targeted Degradation Of Ret And Their Preparation 参考文献:World Intellectual Property Organization]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: M-Chloroperbenzoic Acid Solvents: Dichloromethane; 30 Min,-5 °C; 15 H,Rt 标题:Novel In-Vivo Probe For Real Time Longitudinal Monitoring Of Inducible Nitric-Oxide Synthase In Living Cells And Animals 参考文献:World Intellectual Property Organization]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: M-Chloroperbenzoic Acid Solvents: Dichloromethane; Rt 标题:Preparation Of Substituted 4-(1-Pyrrolidinyl)Pyrimidine Compounds As Dimerization Inhibitors Of Neuronal Nitric Oxide Synthase 参考文献:World Intellectual Property Organization]
49844-90-8 = 97229-11-3 反应条件:1.1 Reagents: M-Chloroperbenzoic Acid Solvents: Chloroform 标题:The Synthesis And Aminolysis Of Some 4-Chloro-2-(Substituted)Thiopyrimidines 作者:Hurst,Derek T.; Johnson,Matthew 参考文献:Heterocycles 日期:1985 卷标:23(3) 页码:611-16]
= 97229-11-3 [标题:Reaction Conditions 标题:Novel In-Vivo Probe For Real Time Longitudinal Monitoring Of Inducible Nitric-Oxide Synthase In Living Cells And Animals 参考文献:India]
= 97229-11-3 [标题:Reaction Conditions 标题:Preparation Of 2-[[(Phenoxy)Pyrimidinyloxy]Phenyl]-3-Methoxypropenoates As Agrochemical Fungicides 参考文献:European Patent Organization
专利号:US-6593347-B2 优先权日:1998-10-30 标题 :Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use 发明人:BANDARAGE UPUL K; DONG QING; FANG XINQIN; GARVEY DAVID S; MERCER GREGORY J; RICHARDSON STEWART K; SCHROEDER JOSEPH D; WANG TIANSHENG 权利人:NITROMED INC 摘要:The present invention describes novel nitrosated and/or nitrosylated nonsteroidal antiinflammatory compounds, and novel compositions comprising at least one nitrosated and/or nitrosylated nonsteroidal antiinflammatory compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase. The present invention also provides methods for treating, preventing and/or reducing inflammation, pain, and fever; decreasing or reversing the gastrointestinal, renal and other toxicities resulting from the use of nonsteroidal antiinflammatory drugs; treating and/or preventing gastrointestinal disorders; treating inflammatory disease states and disorders; and treating and/or preventing ophthalmic diseases or disorders.
专利号:US-6936600-B2 优先权日:1999-04-01 标题:Sorbitol dehrydrogenase inhibitors 发明人:CHU-MOYER MARGARET Y; MYLARI BANAVARA L; ZEMBROWSKI WILLIAM J 权利人:PFIZER 摘要:This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, n n nwherein R 1 , R 2 and R 3 are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds and methods of treating or preventing diabetic complications, particularly diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, diabetic macroangiopathy and diabetic cardiomyopathy by administering such compounds to a mammal suffering from diabetes and therefore at risk for developing such complications. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an aldose reductase inhibitor and to methods of treating or preventing diabetic complications therewith. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an NHE-1 inhibitor and to methods of treating cardiomyopathy and other heart-related problems therewith. This invention is also directed to certain intermediates used in the synthesis of the compounds of formula I and to processes for preparing those intermediates.
专利号:US-9861636-B2 优先权日:2014-04-29 标题 :Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors 发明人:HE WEI 权利人:HE WEI; ZHEJIANG DTRM BIOPHARMA CO LTD 摘要:Described herein is a novel series of multi-fluoro-substituted pyrazolopyrimidine compounds or salts thereof. These compounds are Bruton's tyrosine kinase (BTK) inhibitors. These compounds may possess better BTK inhibition selectivity and pharmacokinetic properties. Disclosed herein are the synthesis methods of these compounds. Disclosed herein are novel synthesis methods of the multi-fluoro-substituted benzophenone and substituted phenoxy benzene. Also disclosed are pharmaceutical compositions comprising the BTK inhibitors described herein. The present invention also relates to pharmaceutical formulations comprising the compounds described herein as active ingredients. The present invention also includes the therapeutic methods by administering the BTK inhibitors and their formulations to treat and inhibit autoimmune disease, hypersensitivity disease, inflammatory diseases and cancer.
专利号:RU-2019543-C1 优先权日:1989-02-10 标题 :Method of pyrimidine derivative synthesis
参考文献:10.1055/s-0033-1338853 摘要:Moon Y, Baiazitov R, Du W, Lee C, Hwang S, Almstead N. Chemoselective Reactions of 4,6-Dichloro-2-(methylsulfonyl)pyrimidine and Related Electrophiles with Amines. Synthesis. 2013 Jun 11;45(13):1764–84. doi: 10.1055/s-0033-1338853. 参考文献:10.1055/s-0037-1609357 摘要:Manganese-Catalyzed Oxidative Kinetic Resolution of Heterocyclic Sulfoxides. Synfacts. 2018 Mar 15;14(04):0374. doi: 10.1055/s-0037-1609357.